helpful analysis ..and thanks. But is an entry price of 5 cents...

First 31 Last

Share
Profile

Follow
rosencrantz

2,779 Posts.

573

17/04/19

17:40

Post #: 38186353
Share

Originally posted by pikel1980 ↑

So I had a few moments today and decided to re-read the terms sheet provided by BLA on the Oaktree Loan.

Essentially it provides some details on the breach provisions - BLA have a cure period, 10 business days for non-payment and 20 business days for other breaches. If the breach event was the 1st April, then they have until the 1st May (lots of holidays in April) to show how they have "made good". But thats a guess, the timeline could be the 15th April for Breach and then 20 business days after that.

Now I'm assuming that the breach is the recurring cash ebita or min cash balance, which could be rectified by showing forecasts for the next period and then sticking to them.

If its a min cash balance, thats harder, but could be rectified if they are selling down funds and collecting the unpaid management fees or performance fees.

So why does this matter, well it could suggest to us a timeline. So I'm thinking that they will be announcing to the market which way this goes around the 1st of May, which means the bloodbath that is the share price will probably continue until then.... Fidelity must be getting closer to another market update on their selldown, I recon close of business tomorrow...

Expand

helpful analysis ..and thanks.
But is an entry price of 5 cents realistic ?..given that the drover's dog could turn up an enterprising fund manager like WAM to orchestrate a buy out of the funds management contracts within the cure period?
would you consider lifting it to 25 cents!

BLA Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

FHE

Frontier Energy achieves key milestone for Waroona energy project

EMD

Emyria's Empax Centre chosen for mental health clinical trial

STX

Strike Energy secures $153 million for Perth Basin gas projects

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

BRX

Belararox delineates another porphyry in Argentina at Tambo South

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing